NCT01446783View on ClinicalTrials.gov

IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Ehlers-Danlos Syndrome, Classic
Interventions
DRUG

mecasermin

0,1 ml mecasermin (10 mg/ml) is injected intratendinous into the patella tendon with ultrasound guidance.

DRUG

Saline

0,1 ml saline is injected intratendinous into the patella tendon with ultrasound guidance.

Trial Locations (1)

2400

Institute of Sportsmedicine Copenhagen, Copenhagen

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT01446783 - IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients | Biotech Hunter | Biotech Hunter